Meaning of Life in HIV-infected Youths
This study has been completed.
Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration
Collaborators:
Chulalongkorn University
Pediatric department, Chulalongkorn University, Bangkok, Thailand
South East Asia Research Collaboration with Hawaii
Wayne State University
University of Minnesota, MN
Information provided by (Responsible Party):
The HIV Netherlands Australia Thailand Research Collaboration
ClinicalTrials.gov Identifier:
NCT01644383
First received: July 17, 2012
Last updated: August 17, 2016
Last verified: August 2016
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Logotherapy has never been evaluated in HIV-infected teenagers. In this study, we will evaluate the meaning of life by using The Purpose in Life Test and the affect of logotherapy in HIV infected youth at HIV-NAT, Thai Red Cross AIDS Research Centre and King Chulalongkorn Memorial Hospital.
| Condition | Intervention |
|---|---|
|
Meaning of Life |
Behavioral: logotherapy |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | Meaning in Life of Youth Infected With HIV |
Resource links provided by NLM:
Further study details as provided by The HIV Netherlands Australia Thailand Research Collaboration:
Primary Outcome Measures:
- PIL score [ Time Frame: week 48 ] [ Designated as safety issue: No ]Change of PIL score at baseline and follow up visit between the two arms
Secondary Outcome Measures:
- QOL [ Time Frame: 48 weeks ] [ Designated as safety issue: No ]
| Enrollment: | 48 |
| Study Start Date: | February 2011 |
| Study Completion Date: | June 2015 |
| Primary Completion Date: | June 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Treatment arm (logotherapy)
Participants in Arm I will attend the logotherapy group sessions by the trained psychologist for 4 visits (see Table II, III). The number of participants in group sessions will be 20 participants per group.
|
Behavioral: logotherapy
Logotherapy is therapy during which the interaction between the therapist and the client centres on the topic of meaning. The problems that the clients experience are presented to the client as inseparable parts of his everyday life. The client is then challenged to discover his/her meaning and to take responsibility in facing up to his/her problem. This approach is aimed at helping the client to deal and understand what his /her existences entail.
|
|
No Intervention: Control arm (general health education)
Participants in Arm II will attend the routine health education by the nurse. The number of participants in group session will be 20 participants per group.
|
Detailed Description:
In the HAART era, HIV infected children can live longer and will grow up to become teenagers. However, some may develop psychosocial problems because they have lost family members, experienced poverty, social discrimination etc. Being a normal teenager is tough and is the most complex period of his/her life. This is the period when most teenagers will find their identity and reasons for living. Therefore it is believed that interventions may help HIV-infected teenagers better deal with life. For this study, logotherapy, a therapy that will help a person to discover his/her purpose in life, live meaningful life, and attain self-esteem was used. The success of the intervention was evaluated by using The Purpose in Life Test.
Eligibility| Ages Eligible for Study: | 16 Years to 24 Years (Child, Adult) |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Age 16-24 years
- HIV seropositive
- HIV disclosed
- Understand Thai language
- Parent signed written informed consent
Exclusion Criteria:
- Mental or psychological disorder or having active suicidal idea or attempt
- Having no permanent address
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01644383
Please refer to this study by its ClinicalTrials.gov identifier: NCT01644383
Locations
| Thailand | |
| HIV-NAT, the Thai Red Cross AIDS Research Centre | |
| Bangkok, Thailand, 10330 | |
Sponsors and Collaborators
The HIV Netherlands Australia Thailand Research Collaboration
Chulalongkorn University
Pediatric department, Chulalongkorn University, Bangkok, Thailand
South East Asia Research Collaboration with Hawaii
Wayne State University
University of Minnesota, MN
Investigators
| Principal Investigator: | Arunya Tuicomepee, PhD | Chulalongkorn University |
More Information
Additional Information:
| Responsible Party: | The HIV Netherlands Australia Thailand Research Collaboration |
| ClinicalTrials.gov Identifier: | NCT01644383 History of Changes |
| Other Study ID Numbers: | HIV-NAT 109 |
| Study First Received: | July 17, 2012 |
| Last Updated: | August 17, 2016 |
| Health Authority: | Thailand: Ethical Committee |
Keywords provided by The HIV Netherlands Australia Thailand Research Collaboration:
|
meaning of life logotherapy HIV-infected teenagers adherence |
ClinicalTrials.gov processed this record on September 30, 2016